
Zolirab D 30mg/20mg Capsule SR
Marketer
Mas Life Science
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Zolirab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD) is effectively managed with the dual-action formulation, Zolirab D 30mg/20mg Sustained-Release Capsules. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and discomfort by neutralizing stomach acid and facilitating gas expulsion. Always adhere to your physician's prescribed dosage and duration; taking Zolirab D on an empty stomach is recommended. Treatment length depends on individual response and overall condition. Premature discontinuation may lead to symptom recurrence and potential worsening of the condition. Complete transparency with your healthcare provider regarding all concurrent medications is crucial due to potential interactions. Commonly reported side effects include diarrhea, abdominal pain, xerostomia, headache, flatulence, and asthenia; most are transient. Consult your doctor immediately if side effects are concerning. Drowsiness and dizziness are possible; avoid driving or tasks requiring alertness until effects are known. Alcohol consumption should be avoided due to potential increased sedation. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, can complement treatment. Prior to commencing Zolirab D, disclose any existing liver or kidney conditions, and inform your doctor of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Zolirab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Zolirab D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zolirab D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Zolirab D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Zolirab D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zolirab D 30mg/20mg SR capsule whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Zolirab D 30mg/20mg Capsule SR works:
Zolirab D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, domperidone, with a proton pump inhibitor (PPI), rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole diminishes gastric acid secretion, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Zolirab D 30mg/20mg SR capsules concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Zolirab D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Zolirab D 30mg/20mg sustained-release capsules while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Zolirab D 30mg/20mg SR Capsules, which can cause drowsiness, dizziness, and blurred vision. Refrain from operating a vehicle if experiencing these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Zolirab D 30mg/20mg sustained-release capsules. Dosage modifications for Zolirab D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Zolirab D 30mg/20mg sustained-release capsules. Dosage modification may be necessary. Medical advice is recommended. Zolirab D 30mg/20mg sustained-release capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Zolirab D 30mg/20mg Capsule SR :
Should you forget to take a Zolirab D 30mg/20mg Capsule SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zolirab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
